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Abstract 
Background: Cryptosporidium is a protozoan parasite which is a common cause of gastroenteritis worldwide. In 
developing countries, it is one of the most important causes of moderate to severe diarrhoea in young children; in 
industrialised countries it is a cause of outbreaks of gastroenteritis associated with drinking water, swimming pools 
and other environmental sources and a particular concern in certain immunocompromised patient groups, where it 
can cause severe disease. However, over recent years, longer-term sequelae of infection have been recognised and a 
number of studies have been published on this topic. The purpose of this systematic review was to examine the litera-
ture in order to better understand the medium- to long-term impact of cryptosporidiosis.
Methods: This was a systematic review of studies in PubMed, ProQuest and Web of Science databases, with no 
limitations on publication year or language. Studies from any country were included in qualitative synthesis, but only 
those in industrialised countries were included in quantitative analysis.
Results: Fifteen studies were identified for qualitative analysis which included 3670 Cryptosporidium cases; eight 
studies conducted in Europe between 2004–2019 were suitable for quantitative analysis, including five case-control 
studies. The most common reported long-term sequelae were diarrhoea (25%), abdominal pain (25%), nausea 
(24%), fatigue (24%) and headache (21%). Overall, long-term sequelae were more prevalent following infection with 
Cryptosporidium hominis, with only weight loss and blood in stool being more prevalent following infection with 
Cryptosporidium parvum. Analysis of the case-control studies found that individuals were 6 times more likely to report 
chronic diarrhoea and weight loss up to 28 months after a Cryptosporidium infection than were controls. Long-term 
abdominal pain, loss of appetite, fatigue, vomiting, joint pain, headache and eye pain were also between 2–3 times 
more likely following a Cryptosporidium infection.
Conclusions: This is the first systematic review of the long-term sequelae of cryptosporidiosis. A better understand-
ing of long-term outcomes of cryptosporidiosis is valuable to inform the expectations of clinicians and their patients, 
and public health policy-makers regarding the control and prevention of this infection.
Systematic review registration PROSPERO Registration number CRD42019141311
Keywords: Cryptosporidiosis, Sequelae, Cryptosporidium hominis, Cryptosporidium parvum
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/




1 Swansea University Medical School, Swansea University, Singleton Park, 
Swansea, UK
Full list of author information is available at the end of the article
Background
Cryptosporidiosis is a clinical disease, typically affect-
ing the intestinal tract of humans and animals who 
have ingested the protozoan parasite Cryptosporid-
ium in its oocyst (infective) stage [1]. Transmission of 
Cryptosporidium occurs predominantly via the faecal-
oral route, or through consumption of contaminated 
food or water and therefore the prevalence of human 
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Cryptosporidium infections is higher in low-resource 
settings [2]. However, Cryptosporidium infections are 
not infrequent in industrialized countries [3], with large 
outbreaks being reported in Sweden [4], the USA [5, 6] 
and the UK [7] following contamination of public water 
supplies.
While asymptomatic carriage is possible [8, 9], human 
cryptosporidiosis typically presents as an acute, gastro-
enteritis-like illness characterized by profuse, watery 
diarrhoea, frequently accompanied by abdominal pain/
cramps, vomiting and weight loss, as well as more non-
specific symptoms such as fatigue, low-grade fever, nau-
sea and muscle weakness [10]. In immunocompetent 
hosts, cryptosporidiosis is generally self-limiting; how-
ever, disease severity can be influenced by host factors, 
such as age, immune status and nutritional status, as well 
as pathogen factors e.g. Cryptosporidium species and 
subtype [11].
Alongside ongoing interest in the acute symptomology 
of human cryptosporidiosis, there is also growing evi-
dence to suggest that, rather like some bacterial causes of 
gastroenteritis and giardiasis [12–14], Cryptosporidium 
infection may have longer-term health consequences. 
Seven studies [15–21], with follow-up periods rang-
ing from 2 months to 3 years, have investigated numer-
ous potential post-Cryptosporidium infection sequelae 
including diarrhoea, abdominal pain, vomiting, loss of 
appetite, irritable bowel syndrome (IBS) [21], joint pain 
and fatigue, while case reports document incidences of 
reactive arthritis [22–24], Reiter’s syndrome [25], acute 
pancreatitis [26, 27] and haemolytic uremic syndrome 
[28], in the context of Cryptosporidium infection. There 
is also some emerging evidence, recently reviewed, of a 
possible association between cryptosporidiosis and can-
cer [29].
Due to resource limitations, public health professionals 
currently face the challenge of identifying and prioritis-
ing specific infectious diseases whose quantified burden 
of disease estimates justify the allocation of interven-
tions and funding for research [30]. The Global Enteric 
Multicentre Study [31] identified Cryptosporidium as 
the second most common cause of moderate-to-severe 
diarrhoea (MSD; defined as diarrhoeal disease with pres-
ence of the suggestive features of sunken eyes, wrinkled 
skin, hospitalization, receipt of intravenous hydration, 
or dysentery) in children less than 2 years-old within 
sub-Saharan Africa and south Asia, while in 2016, the 
European Network for Foodborne Parasites (Euro-FBP) 
ranked Cryptosporidium spp. as the second highest pri-
ority foodborne parasite in northern and western Europe, 
and the eighth highest priority in eastern and south-
western Europe [30]. However, actual burden of disease 
estimates for Cryptosporidium still vary widely [11] and 
it remains difficult to quantify the true burden of crypto-
sporidiosis, as current estimates only account for the 
morbidity and mortality associated with the acute illness, 
while the potential contributions of long-term manifesta-
tions are not included [32, 33]. A recent study from the 
Netherlands [2] found that long-term manifestations 
contributed nearly 10% of the total Disability-Adjusted 
Life Years (DALYs) and costs when included in burden of 
disease models for Cryptosporidium, suggesting a higher 
public heath burden and cost than previously estimated.
Accurate estimations of the burden of disease asso-
ciated with Cryptosporidium will inform decisions 
regarding the allocation of diagnostic, surveillance and 
interventional measures to prevent and control Crypto-
sporidium infections. Due to the potential morbid-
ity and mortality associated with long-term sequelae 
of human cryptosporidiosis, an accurate estimation of 
the proportion of cases that develop such sequelae is 
needed to quantify true burden of disease estimates for 
Cryptosporidium.
The objectives of this review were: (i) estimate the 
proportion of people that self-report health sequelae 
post-Cryptosporidium infection; (ii) estimate the risk of 
specific sequelae following Cryptosporidium infection; 
and (iii) explore potential risk factors associated with 




We searched for studies in PubMed, ProQuest and Web 
of Science databases, with no limitations on publica-
tion year or language. The reference lists from relevant 
papers identified during our electronic searches were also 
reviewed for additional relevant papers which may war-
rant inclusion in our review. Search terms were initially 
developed and piloted using PubMed and, to ensure con-
sistency, the same search terms were used when search-
ing ProQuest and Web of Science databases. Databases 
were searched using the following keywords: Crypto-
sporid*, Complications, Sequel*, Post-infecti*, Long term 
and Chronic. The full electronic search strategies are 
documented in Additional file  1: Table  S1. The review 
was registered with PROSPERO, registration number 
CRD42019141311.
Selection of studies
All citations identified using the final search strate-
gies were exported to Mendeley® reference managing 
software for organisation and removal of duplicates. 
The titles and abstracts of the remaining articles were 
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screened for relevance by one reviewer (BC), after which, 
the remaining articles were independently screened by 
two reviewers (BC and APD) to ensure consistent appli-
cation of the pre-determined inclusion/exclusion criteria 
(Additional file 1: Table S1).
Studies from any country were included in qualitative 
synthesis, but only those in industrialised countries were 
included in quantitative analysis. An industrialised coun-
try was defined using Organisation for Economic Co-
operation & Development (OECD) membership.
Final inclusion of studies was decided by consensus, 
with any conflicts being reviewed by a third reviewer 
(RMC). The full text was retrieved and reviewed for arti-
cles where the title and abstract had been deemed rele-
vant by reviewers.
Data extraction
Data were extracted from eligible studies and collated in 
a Microsoft Word document. We recorded post-Crypto-
sporidium infection health sequelae data as reported in 
the individual papers (e.g. prevalence, cumulative inci-
dence, etc.). Relative risks or odds ratios were recorded 
where data were available. We also extracted the follow-
ing study characteristics from each paper if available: 
name of authors, year of publication, study location/
setting, study design, year(s) of study, study duration 
and duration of follow-up, number of included study 
participants, participation rate, study population demo-
graphics (including age and gender distributions), 
Cryptosporidium species data, the diagnostic method 
to ascertain Cryptosporidium infection and the types of 
sequelae reported. Additionally, where available, data on 
the incidence/prevalence of post-infectious IBS following 
Cryptosporidium infection and the IBS diagnostic crite-
rion applied were collected.
Quality assessment
The methodological quality of the included studies was 
assessed using the Newcastle-Ottawa Scale (NOS) for 
nonrandomised studies [34]. NOS was used to score 
studies using three domains: (i) the selection of the study 
groups; (ii) the comparability of the groups; and (iii) the 
determination of either the exposure or outcome of inter-
est in case-control or cohort studies, respectively. Scores 
ranged between 5–8 (Additional file 1: Table S2).
Statistical analysis
The proportion of Cryptosporidium cases that devel-
oped specific sequelae was calculated by dividing the 
number of individuals developing a sequela by the total 
number of Cryptosporidium cases. Where data were 
available from two or more appropriate studies, we used 
a random-effects meta-analysis model to obtain pooled 
estimates of prevalence for the outcomes of interest (i.e. 
sequelae) across the eligible studies. For this analysis, a 
study could be included more than once if sequelae data 
were reported longitudinally at different time periods. 
Data analyses were performed using Meta XI [35].
Assessment of heterogeneity and reporting biases
Forest plots and the  I2 statistic were used to assess heter-
ogeneity between the studies. Values of 0–40%, 30–60%, 
50–90% and 75–100% were interpreted as; might not be 
important, may represent moderate heterogeneity, may 
represent substantial heterogeneity and considerable het-
erogeneity, respectively [36]. Funnel plots were used to 
assess for publication bias and small-study effects.
Stratified analysis was performed for the following sub-
groups; time (less than 6 months post-infection and more 
than 6 months post-infection) and Cryptosporidium sp. 
(e.g. C. parvum vs C. hominis).
Results
Data synthesis
The number of papers identified, included and excluded 
is presented according to the requirements of the 
PRISMA statement [37] in Fig.  1. Fifteen studies were 
identified for qualitative synthesis and eight of these were 
identified as being set in industrialised countries and of 
sufficient quality for additional quantitative synthesis.
The qualitative synthesis is shown in Table 1. Quantita-
tive synthesis results are shown in Tables 2, 3 and 4 and 
Figs. 2 and 3.
Qualitative synthesis
Electronic searching returned 1251 PubMed, 2161 Pro-
Quest and 3227 Web of Science abstracts. After removal 
of duplicates, screening and assessment, 15 articles were 
suitable for inclusion in the qualitative synthesis and the 
data extracted from these studies are summarized in 
Table 1.
The 15 shortlisted studies included 3670 Cryptosporid-
ium cases. The studies comprised 8 cohort studies and 
7 case-control studies. Seven studies were conducted in 
children, with the remaining 8 studies including both 
adults and children. The length of duration of follow-
up ranged from 2 months to 9 years. Studies were con-
ducted in South America (3 studies), Africa (1 study), 
South Asia (2 studies) and Europe (9 studies) and were all 
based in a community setting. The selected studies were 
published between 1992 and 2019. The studies investi-
gated a range of potential sequelae; diarrhoea (3 studies), 
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developmental delay (2 studies), stunting of growth (4 
studies) and multiple gastrointestinal and non-gastroin-
testinal symptoms (8 studies).
Quantitative synthesis
Adequate information to estimate post-Cryptosporidium 
infection sequelae was available in 8 of the 15 studies [4, 
15–21]. The pooled estimates for each of the sequelae are 
shown in Table  2. Data for each individual sequela are 
available in Additional file 2.
The eight studies were conducted in Europe between 
2004 and 2019; four in Sweden, three in the UK and 
one in the Netherlands. The sequelae investigated 
were mostly gastrointestinal, with some non-gastro-
intestinal symptoms such as joint pain and eye pain 
and most recruited cases were adults. This was in con-
trast to studies in non-industrialised countries which 
focused on growth, nutrition and cognitive detriment 
in children.
The most frequently investigated sequelae are listed in 
Table 2 and included diarrhoea, abdominal pain, vomit-
ing, fatigue, joint pain, eye pain and headache.
The most common reported long-term sequelae were 
diarrhoea (25%), abdominal pain (25%), nausea (24%), 
fatigue (24%) and headache (21%). The distribution of 
gastrointestinal manifestations and non-gastrointestinal 
manifestations reported is shown in Fig. 2.
Subgroup analysis
Table  3 shows the pooled estimates for the prevalence 
of post-Cryptosporidium sequelae by time period post-
infection. With the exception of eye pain and headache, 
all sequelae were more frequently reported within 6 
months of Cryptosporidium infection.
In all eight studies included in the quantitative analy-
sis, species identification of Cryptosporidium had been 
performed. Four were outbreak cohort follow-up stud-
ies so contained only one species (three contained C. 
hominis cases exclusively and one contained C. parvum 
exclusively). The other four studies contained both spe-
cies; one of these four also contained a small number 
of other species (17/271 cases), but because of the low 
numbers, these have not been considered here. Figure 3 
shows the pooled estimates for the prevalence of post-
Cryptosporidium sequelae by Cryptosporidium species. 
Overall, long-term sequelae were more prevalent follow-
ing infection with C. hominis, with only weight loss and 
blood in stool being more prevalent following infection 
with C. parvum. IBS was reported in 11% of cases, how-
ever, it should be noted that data for this outcome were 
only available from 2 studies, one of which only studied 
C. parvum cases.
Sequelae risk
Five of the 8 qualitative synthesis studies included a 
control group. A limited evaluation of risk of individual 
sequelae using the five case-control studies available was 
undertaken [4, 15, 17, 19, 20]. Data were available for 10 
sequelae (Table 4).
Individuals were 6 times more likely to report chronic 
diarrhoea and weight loss up to 28 months after a Crypto-
sporidium infection than controls. Long-term abdominal 
pain, loss of appetite, fatigue, vomiting, joint pain, head-
ache and eye pain were also 2–3 times more likely follow-
ing a Cryptosporidium infection (Fig. 4).
To view the PRISMA checklist relating to this work, 
please see Additional file 3.
Discussion
Of the 15 studies investigating long-term sequelae, 
just over half were set in industrialised countries. In 
contrast to those in non-industrialised settings, these 
involved mainly adult cases, with the inclusion of some 
children. Half were outbreak cohort studies, with the 
rest involving sporadic community cases. Studies from 
non-industrialised countries involved exclusively chil-
dren, reflecting the greater clinical importance and 
recognition of paediatric infection in such settings. In 
industrialised countries there is more focus on detect-
ing sporadic community cases of cryptosporidiosis in 
all age groups, partly in order to facilitate early detec-
tion of community outbreaks, for example from drink-
ing water, swimming pools, or other environmental 
sources. The studies in non-industrialised countries 
also differed in that the children were recruited and 
tested as part of the specific studies, whilst the studies 
in industrialised countries relied on cases initially diag-
nosed routinely.
The eight studies suitable for inclusion in the quantita-
tive analysis were all carried out in just three countries 
in Europe (UK, Sweden and the Netherlands), where 
species data are routinely generated and all except one 
[11] were relatively recent, dated between 2013–2019. In 
many non-industrialised countries, or in earlier European 
studies, species identification would not be routinely per-
formed, and this is reflected in the study data. The geo-
graphical reach of the eight studies is somewhat limited, 
since they were all located in northwest Europe. Only 
five were case-control studies, and of these, only two 
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included both C. hominis and C. parvum, with the other 
three limited to studying C. hominis alone following out-
breaks. Since the bulk of the cryptosporidiosis burden is 
found in low-income countries, there is a need in future 
to conduct similar quantitative evaluations using data 
from developing countries, where obtaining suitable data 
may be more challenging.
There were some limitations to this review. The role of 
genotype in long-term outcomes could not be explored. 
Typing was undertaken by gp60 sequencing in three of 
the studies but was either not analysed with symptoms 
data [16], or was an outbreak where all had the same 
subtype [4, 18]. There were insufficient data to compare 
between studies. Another limitation was that since not 
Fig. 1 PRISMA flowchart
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all cases were necessarily tested for all gastrointestinal 
pathogens, or the results of such tests were not stated, 
long-term sequelae identified cannot be proven to be 
Cryptosporidium-specific and not due to other infectious 
agents.
Most of the studies examined quantitatively were 
concentrated on adult individuals, whereas crypto-
sporidiosis is commonest in young children. This 
over-representation of adults results from the fact that 
several of the studies followed large waterborne out-
breaks involving many adults, rather than sporadic 
cases. Identifying and defining sometimes rather non-
specific sequelae is more difficult in very young children. 
However, a study by Carter et al. [21] of sporadic cases 
did include children, and in fact this study found that 
the proportion developing IBS or IBS-like symptoms 
was higher in children than in adults, with 78% report-
ing it among 5–17 years-old and 63% at 6  months to 
4 years-old.
The results indicate that sequelae are frequently 
reported after cryptosporidiosis lasting up to at least 
2  years. Only one study investigated cases for longer, 
up to 36 months [11]. For both main infecting species, 
sequelae occur, but there are differences in the fre-
quency of each depending on the species. Following 
the publication of the first study in 2004 [15], the evi-
dence base surrounding post-Cryptosporidium infection 
sequelae has continued to expand [16–21]. Gastroin-
testinal sequelae such as continuing diarrhoea, nausea 
and abdominal pain appear particularly common, each 
reported by around a quarter of cases up to 36 months 
post-infection, with analysis of the case-control studies 
Table 2 Pooled estimates for the prevalence of post-
Cryptosporidium sequelae using a random effects model
Note: Studies were included more than once if outcomes were reported at more 
than one interval




Diarrhoea 13 25 (10–44) 1382.71 < 0.001
Abdominal pain 13 25 (13–39) 575.30 < 0.001
Joint pain 13 15 (12–19) 63.28 < 0.001
Fatigue 13 24 (13–37) 477.50 < 0.001
Vomiting 10 8 (5–12) 72.61 < 0.001
Headache 10 21 (12–33) 271.21 < 0.001
Eye pain 10 10 (7–14) 46.66 < 0.001
Loss of appetite 9 19 (14–24) 51.32 < 0.001
Weight loss 9 13 (7–20) 97.98 < 0.001
Nausea 8 24 (11–40) 263.50 < 0.001
Blood in stool 7 3 (2–6) 17.26 0.01
Dizzy spells 6 8 (5–12) 13.24 0.02
Fever 5 13 (4–25) 51.28 < 0.001
Blurred vision 5 6 (4–8) 5.19 0.27
IBS 3 11 (6–16) 0.11 0.95
Table 3 Pooled prevalence of post-Cryptosporidium sequelae 
estimated by a random effects model, according to clinical 
manifestation by time period post-infection





 Diarrhoea 5 43 (12–77) 532.73 < 0.001
 Abdominal 
pain
5 41 (16–68) 278.61 < 0.001
 Loss of appe-
tite
4 26 (21–32) 8.11 0.04
 Nausea 3 37 (59–69) 82.86 < 0.001
 Fatigue 5 39 (17–63) 227.41 < 0.001
 Weight loss 4 22 (19–26) 3.20 0.36
 Fever 3 15 (2–33) 37.77 < 0.001
 Vomiting 5 9 (3–16) 47.83 < 0.001
 Joint pain 5 18 (15–21) 5.75 0.22
 Headache 5 21 (5–42) 215.84 < 0.001
 Dizzy spells 4 9 (5–14) 10.81 0.01
 Eye pain 5 9 (4–15) 35.88 < 0.001
 Blurred vision 3 5 (3–7) 2.10 0.35
 Blood in stool 3 4 (3–6) 0.00 1
> 6 months
 Diarrhoea 8 16 (13–22) 31.14 < 0.001
 Abdominal 
pain
8 16 (9–25) 71.17 < 0.001
 Loss of appe-
tite
5 14 (10–18) 8.68 0.07
 Nausea 5 18 (13–25) 19.47 < 0.001
 Fatigue 8 16 (9–26) 80.85 < 0.001
 Weight loss 5 6 (4–9) 6.50 0.16
 Fever 2 10 (3–21) 2.57 0.11
 Vomiting 5 7 (3–12) 21.53 < 0.001
 Joint pain 8 14 (9–19) 45.27 < 0.001
 Headache 5 22 (12–34) 52.38 < 0.001
 Dizzy spells 2 6 (2–11) 0.04 0.84
 Eye pain 5 12 (7–14) 8.84 0.07
 Blurred vision 2 9 (4–14) 0.01 0.94
 Blood in stool 4 3 (0–6) 11.78 0.01
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finding that persistent diarrhoea is around six times 
more likely than in controls and weight loss over three 
times more likely over 28 months. Fatigue and headache 
were also commonly reported and occurred in the case-
control studies between two-three times more com-
monly in cases than controls over the same time period. 
Overall, the most commonly reported long-term seque-
lae were diarrhoea (25%), abdominal pain (25%), nausea 
(24%), fatigue (24%) and headache (21%). Where it was 
investigated, there was evidence that symptoms meet-
ing the definition for IBS were described just over 10% of 
cases up to 36 months.
Conclusions
This is the first systematic review of the long-term seque-
lae of cryptosporidiosis. The proportion of cases self-
reporting sequelae post-infection has been estimated and 
estimates of risk of specific sequelae presented. Risk fac-
tors for sequelae were less well identified. A better under-
standing of the long-term outcomes of cryptosporidiosis 
is valuable to inform the expectations of clinicians and 
their patients and public health policy makers regarding 
the control and prevention of this infection.
Table 4 Pooled risk ratio of individual post-Cryptosporidium 
sequelae
Abbreviation: RR, risk ratio
Sequelae No. of studies Pooled RR
(95% CI)
Cochranʼs Q P-value
Diarrhoea 5 6.7 (2.63–17.03) 105.37 < 0.001
Abdominal pain 5 2.99 (1.56–5.72) 107.10 < 0.001
Loss of appetite 4 1.98 (1.48–2.63) 8.03 0.05
Nausea 3 2.89 (1.15–7.30) 56.77 < 0.001
Fatigue 5 2.56 (1.47–4.48) 108.43 < 0.001
Weight loss 4 3.65 (1.66–8.03) 22.83 < 0.001
Vomiting 5 2.56 (1.27–5.15) 32.38 < 0.001
Joint pain 5 2.26 (1.35–3.77) 34.30 < 0.001
Headache 5 2.23 (1.22–4.09) 97.31 < 0.001
Eye pain 5 1.98 (1.09–3.59) 28.90 < 0.001
Fig. 2 Reported sequelae up to 36 months post-Cryptosporidium infection
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Fig. 3 Reported sequelae up to 36 months post-Cryptosporidium infection by species (%)
Fig. 4 Pooled risk ratio of individual post-Cryptosporidium sequelae showing 95% confidence intervals
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